Advertisement

Reactions Weekly

, Volume 1760, Issue 1, pp 3–3 | Cite as

Imovane: risk of drug abuse, dependence

News item
  • 27 Downloads

Reference

  1. National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Imovane (zopiclone): New restriction of the indication and additional warnings on abuse and dependence. Internet Document : 20 Jun 2019. Available from: URL: https://www.npra.gov.my/index.php/en/component/content/article/414-english/safety-alerts-main/safety-alerts-2019/

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations